Wave Life Sciences, Inc. cotiza a 3.28 USD y tiene una capitalización bursátil de $646M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Wave Life Sciences, Inc., a clinical-stage biotechnology company, focuses on unlocking the potential of ribonucleic acid (RNA) medicines to transform human health. Its RNA medicines platform, PRISM, combines RNA medicine modalities, chemistry innovation, and deep insights in human genetics to deliver scientific breakth…
| Periodo | 2026-11 | 2026-07 | 2026-04 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.34 | $-0.13 | $-0.30 |
| Estimado | $-0.32 | $-0.30 | $-0.31 | $-0.26 |
| Sorpresa | — | -13.3% | +58.1% | -15.4% |
| Métrica | WVE | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -504.1% | -38.6% | -465.5% |
| Net Margin | -478.3% | -33.6% | -444.8% |
| FCF Margin | -440.5% | -13.9% | -426.6% |
| ROE | -39.4% | -40.4% | +1.0% |
| ROA | -32.0% | -32.0% | 0.0% |
| Current Ratio | 6.47 | 2.84 | +3.63 |
| Debt / Equity | — | 0.28 | — |